Cannabinoids remove plaque-forming Alzheimer's proteins from brain cells
7 hours ago
- #Neuroprotection
- #Alzheimer’s
- #THC
- Preliminary lab studies at the Salk Institute show THC reduces amyloid beta proteins in human neurons, linked to Alzheimer’s disease.
- THC and other marijuana compounds may help remove amyloid beta and reduce inflammation in nerve cells, offering potential therapeutic insights.
- The study suggests cannabinoids could be neuroprotective by affecting both inflammation and amyloid beta accumulation, a novel finding in Alzheimer’s research.
- Alzheimer’s disease affects over 5 million Americans and is a leading cause of dementia, with incidence expected to triple in the next 50 years.
- The research highlights the role of endocannabinoids in brain cell signaling and their potential to protect neurons from amyloid beta-induced damage.
- The findings are exploratory and conducted in lab-grown neurons, necessitating further clinical trials for therapeutic applications.
- Related research identified a drug candidate, J147, which also removes amyloid beta and reduces inflammation in nerve cells and the brain.